Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis.
OBJECTIVE
To determine whether an association exists between mean platelet volume (MPV) and acute myocardial infarction (AMI) and other cardiovascular events. Platelet activity is a major culprit in atherothrombotic events. MPV, which is widely available in clinical practice, is a potentially useful biomarker of platelet activity in the setting of cardiovascular disease.


RESULTS
We performed a systematic review and meta-analysis investigating the association between MPV and AMI, all-cause mortality following myocardial infarction, and restenosis following coronary angioplasty. Results were pooled using random-effects modeling. Pooled results from 16 cross-sectional studies involving 2809 patients investigating the association of MPV and AMI indicated that MPV was significantly higher in those with AMI than those without AMI [mean difference 0.92 fL, 95% confidence interval (CI) 0.67-1.16, P < 0.001). In subgroup analyses, significant differences in MPV existed between subjects with AMI, subjects with stable coronary disease (P < 0.001), and stable controls (P < 0.001), but not vs. those with unstable angina (P = 0.24). Pooled results from three cohort studies involving 3184 patients evaluating the risk of death following AMI demonstrated that an elevated MPV increased the odds of death as compared with a normal MPV (11.5% vs. 7.1%, odds ratio 1.65, 95% CI 1.12-2.52, P = 0.012). Pooled results from five cohort studies involving 430 patients who underwent coronary angioplasty revealed that MPV was significantly higher in patients who developed restenosis than in those who did not develop restenosis (mean difference 0.98 fL, 95% CI 0.74-1.21, P < 0.001).


CONCLUSIONS
Elevated MPV is associated with AMI, mortality following myocardial infarction, and restenosis following coronary angioplasty. These data suggest that MPV is a potentially useful prognostic biomarker in patients with cardiovascular disease. Whether the relationship is causal, and whether MPV should influence practice or guide therapy, remains unknown.
Chu
S G
SG
University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Becker
R C
RC
Berger
P B
PB
Bhatt
D L
DL
Eikelboom
J W
JW
Konkle
B
B
Mohler
E R
ER
Reilly
M P
MP
Berger
J S
JS
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000401:mortality; D001792:Blood Platelets / Q000473:pathology*; D048429:Cell Size; D003324:Coronary Artery Disease / Q000097:blood / Q000401:mortality / Q000628:therapy*; D023903:Coronary Restenosis / Q000097:blood / Q000209:etiology* / Q000401:mortality; D005260:Female; D006801:Humans; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000209:etiology* / Q000401:mortality; D016017:Odds Ratio; D010976:Platelet Count; D010979:Platelet Function Tests; D011237:Predictive Value of Tests; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors
Platelets. 2007 Feb;18(1):16-23
17365849
Thromb Res. 2006;117(4):371-7
15935453
Blood. 1995 Jul 15;86(2):419-31
7605981
Blood. 1988 Jul;72(1):1-8
3291975
Am J Med. 1978 Apr;64(4):542-6
347931
Thromb Res. 1983 Dec 1;32(5):443-60
6658722
Platelets. 2008 Mar;19(2):111-4
17852772
Ann Intern Med. 1997 Nov 1;127(9):820-6
9382404
Lancet. 1991 Dec 7;338(8780):1409-11
1683417
Stat Med. 2002 Jun 15;21(11):1539-58
12111919
Clin Cardiol. 2001 May;24(5):405-8
11346249
J Thromb Thrombolysis. 2008 Aug;26(1):49-54
17705053
Blood. 2009 Apr 16;113(16):3831-7
19221038
Platelets. 2001 Aug;12(5):292-7
11487381
J Clin Pathol. 2006 Feb;59(2):146-9
16443728
J Am Coll Cardiol. 1999 Mar;33(3):634-9
10080462
Int J Clin Pract. 2005 Aug;59(8):981-2
16033624
J Am Coll Cardiol. 2005 Jul 19;46(2):284-90
16022956
Br J Haematol. 1983 Jul;54(3):337-52
6860588
Thromb Haemost. 1988 Apr 8;59(2):259-63
3388297
J Clin Invest. 1969 Jun;48(6):1083-7
5771189
Medicina (Firenze). 1988 Jan-Mar;8(1):58-60
3226247
Arterioscler Thromb Vasc Biol. 1997 Apr;17(4):802-7
9108797
N Engl J Med. 2007 Dec 13;357(24):2482-94
18077812
J Hum Hypertens. 2000 Sep;14(9):581-5
10980590
Br Med J (Clin Res Ed). 1983 Aug 13;287(6390):456-9
6411172
Thromb Haemost. 2001 Jun;85(6):989-94
11434707
Blood. 2004 Mar 15;103(6):2096-104
14630798
Circ Res. 2007 May 11;100(9):1261-75
17495233
N Engl J Med. 1971 Jan 7;284(1):11-7
5099586
N Engl J Med. 1990 May 31;322(22):1549-54
2336086
J Clin Invest. 2005 Dec;115(12):3378-84
16322783
Eur J Clin Invest. 1994 Jul;24(7):488-98
7957507
Acta Cardiol. 2004 Aug;59(4):391-5
15368800
Med Sci Monit. 2005 Aug;11(8):CR387-92
16049381
BMJ. 1997 Sep 13;315(7109):629-34
9310563
Platelets. 2004 Dec;15(8):475-8
15763888
Eur Heart J. 2001 Sep;22(17):1561-71
11492985
Br Med J (Clin Res Ed). 1983 Aug 13;287(6390):449-51
6411169
Clin Sci (Lond). 1985 Apr;68(4):419-25
3971672
Thromb Haemost. 1987 Aug 4;58(2):714-7
3672422
J Thromb Thrombolysis. 2008 Apr;25(2):135-40
17574521
Clin Lab Haematol. 1992;14(4):281-7
1478007
Eur J Clin Invest. 1994 Jan;24(1):69-72
8187810
Eur Heart J. 1992 Feb;13(2):166-70
1313369
Science. 1991 Sep 6;253(5024):1129-32
1653454
Br Med J (Clin Res Ed). 1983 Nov 12;287(6403):1471
6416464
Diabetes Res Clin Pract. 1988 May 19;5(1):63-9
3402334
Am Heart J. 1995 Oct;130(4):711-6
7572577
Acta Med Scand. 1986;220(5):401-5
3812027
Rev Esp Cardiol. 1998 Oct;51(10):816-22
9834631
J Am Coll Cardiol. 2007 Nov 6;50(19):1822-34
17980247
J Am Coll Cardiol. 2008 Aug 26;52(9):743-9
18718422
N Engl J Med. 1986 Oct 16;315(16):983-9
3531859
Thromb Haemost. 1984 Oct 31;52(2):167-71
6523435
Blood. 1981 Feb;57(2):199-202
6160890
Blood. 1983 Aug;62(2):487-94
6871471
Acta Cardiol. 2004 Jun;59(3):263-8
15255457
Blood Coagul Fibrinolysis. 1996 Mar;7(2):157-61
8735807
Ann Med. 2004;36(7):552-7
15513305
Prog Growth Factor Res. 1991;3(3):177-206
1811790
Eur J Clin Invest. 1993 Jun;23(6):361-7
8344336
J Lab Clin Med. 1985 Feb;105(2):271-6
3882862
BMJ. 2008 Jan 26;336(7637):195-8
18202034